Todd E. Simpson, Chief Financial Officer at SEATTLE GENETICS INC /WA (SGEN), sold 40,000 shares at $164.96 ($6.6M) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Seasonal sale ($6.6M) by Chief Financial Officer — this insider has traded SGEN in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $164.96 | 7,720 | $1.3M | 19.2% |
| 2 | $164.96 | 7,720 | $1.3M | 19.2% |
| 3 | $166.10 | 10,375 | $1.7M | 26.0% |
| 4 | $166.10 | 10,375 | $1.7M | 26.0% |
| 5 | $166.74 | 1,905 | $318K | 4.8% |
| 6 | $166.74 | 1,905 |
| $318K |
| 4.8% |
| Total | $165.72 avg | 40,000 | $6.6M | 100% |
| Filing → |
| SGEN | SELL | 2023-08-30 | $100K | — | Filing → |
| SGEN | SELL | 2023-04-12 | $22.6M | — | Filing → |
| SGEN | SELL | 2023-04-07 | $100K | — | Filing → |